Clinical Trial

Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.

Study acronym: VasOSA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this prospective cohort study is to study patients referred for sleep study by in-lab polysomnography in the Jordan University Hospital and the Jordan Hospital or with an at-home sleep study kit. The main aims are: * To prospectively obtain demographic and clinical information of patients referred for a sleep study. * To determine the diagnostic value of facial discoloration as potential marker for obstructive sleep apnea to increase detection rate for the condition. * To establish a correlation between obstructive sleep apnea and vasovagal symptoms with resulting increased smoking tendency and study the effect of treatment on the disorders. * To determine the association between timing of appearance of obstructive sleep apnea symptoms and initiation of smoking.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-19.
Trial Details
NCT Number NCT06331819
Lead Sponsor Jordan Collaborating Cardiology Group
Conditions Obstructive Sleep Apnea, Vasovagal Syncope, Smoking, Acanthosis Nigricans
Enrollment 200 participants
Start Date 2024-03-10
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19